Trial intelligence / Profile preview

Drug-drug interaction study of bitopertin (RO4917838) in healthy adult male volunteers

jRCT2080221964Phase 1

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of bitopertin, sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Primary pharmacokinetic interaction endpoints.

02

Drugs

bitopertin

Beyond the preview

Go deeper on jRCT2080221964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call